Get informed when a big investor buys or sells
+ FollowOvervalued by 51.9% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $2.93 Billion |
|---|---|
| Enterprise Value | $-46,383,854,787.00 |
| Annual dividend | $0.66 |
| Dividend yield | 1.49% |
| Earnings per Share | $49.19 |
| Beta | 0.25 |
| Outstanding Shares | 74,338,617 |
| P/E Ratio | 114.4 |
|---|---|
| PEG | 145.11 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 2.84 |
| Enterprise Value to EBIT | 41.46 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and international...